UNC Lineberger Comprehensive Cancer Center: Pancreatic Neoplasms trials
The registry lists 12 Pancreatic Neoplasms studies with UNC Lineberger Comprehensive Cancer Center as lead sponsor. 8 are open to participants now and 1 have results posted.
Phase 1 5Phase 2 3No phase 5(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- The STRONG Nutrition Support Study for People With Pancreatic CancerNot yet recruitingNCT07826780Not applicable
- A Decision Support Tool for Pancreatic Cancer Screening -Aim 2Not yet recruitingNCT07808671Not applicable
- SURGIMEDIA: Utilization of Multimedia for Enhanced Surgical ConsentNot yet recruitingNCT07494994Not applicable
- Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxelRecruitingNCT06483555Phase 1/2
- Promoting CT Engagement for Pancreatic Cancer With AppRecruitingNCT06252545Not applicable
- Autologous CAR-T Cells Targeting B7-H3 in PDACRecruitingNCT06158139Phase 1
- Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic CancerRecruitingNCT03977233Phase 2
- Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid TumorsRecruitingNCT03454035Phase 1
- FOLFIRINOX for Unresectable Locally Advanced and Borderline Resectable Pancreatic CancerTerminatedNCT01688336Phase 2Results posted
- Mobile Weight Loss Intervention for Adolescent and Young Adult Cancer SurvivorsCompletedNCT06171945Not applicable
- BKM120 + mFOLFOX6 in Advanced Solid Tumors With Expansion Cohort Pancreatic CancerCompletedNCT01571024Phase 1
- Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract CancerCompletedNCT00266097Phase 1